查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1737214

透明质酸注射治疗关节痛的市场规模及预测

Hyaluronic Acid Injections For Joint Pain Market Size And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年用于治疗关节痛的透明质酸注射剂市场规模为 44.1 亿美元，预计到 2032 年将达到 69.9 亿美元，2026 年至 2032 年的复合年增长率为 5.93%。

推动全球透明质酸注射剂治疗关节疼痛市场的因素

用于治疗关节痛的透明质酸注射剂市场的市场驱动因素可能受到多种因素的影响。

  • 人口老化：随着全球人口老化，骨关节炎等关节相关疾病日益普遍。玻尿酸注射是一种微创治疗方法，可以缓解关节不适并改善关节功能，满足老化社会的需求。骨关节炎是最常见的关节炎类型，影响全球数百万人。其发病率正在上升。由于老龄化、肥胖和久坐不动的生活方式等因素，骨关节炎变得越来越普遍，因此对透明质酸注射等有效治疗方案的需求也日益增长，以减轻关节不适并改善活动能力。
  • 偏好非手术治疗：在接受关节重建等侵入性手术之前，许多患者更倾向于采用非手术方法来缓解关节不适。玻尿酸注射是一种非侵入性治疗关节疼痛、缓解不适并改善关节功能的方法，无需承担手术带来的风险和漫长的恢復期。
  • 技术发展：医疗技术的进步使得透明质酸注射剂型和给药方法更加完善。这些进步提高了治疗的有效性、安全性和患者舒适度，从而提高了患者和医护人员的接受度。
  • 注重疼痛管理和生活品质提升：骨关节炎等慢性疾病患者越来越重视疼痛管理和生活品质提升。玻尿酸注射可以帮助患者有针对性地控制疼痛，继续日常活动，并拥有更美好的生活。
  • 医疗基础设施不断增长：医疗基础设施的不断增长，尤其是在新兴经济体，促进了人们获得诸如透明质酸注射等治疗关节疼痛的医疗疗法。这种扩张使得关节问题的诊断和治疗变得更加容易，从而扩大了相关治疗和疗法的市场。
  • 医疗保健支出不断增长：随着个人和政府医疗保健支出的增加，用于治疗关节疼痛的透明质酸注射市场正在不断扩大。玻尿酸注射及相关疗法的市场成长动力源自于患者愿意花钱购买能改善整体生活品质并有效缓解疼痛的疗法。
  • 临床证据和患者满意度：越来越多的临床证据表明透明质酸注射治疗关节疼痛的安全性和有效性，以及积极的患者体验和疗效，正在推动市场扩张。经过深入研究并被证明真正有效的治疗方法更有可能被患者和医疗保健专业人员采用。

限制透明质酸注射剂治疗关节痛的全球市场的因素

多种因素可能会对玻尿酸注射治疗关节痛市场造成限制和挑战。

  • 治疗费用高昂：玻尿酸注射费用较高，尤其需要长期重复注射的患者。高昂的费用可能会阻碍患者获得治疗，尤其是对于缺乏足够保险或经济能力的患者。
  • 保险覆盖范围有限：在某些地区，透明质酸注射的保险覆盖范围可能很少或不稳定，这可能会限制患者获得治疗的机会，因为患者必须自掏腰包支付治疗费用，特别是如果他们没有健康保险或收入较低。
  • 疗效差异：透明质酸注射的效果因人而异。有些人的疼痛得到显着缓解，关节功能得到改善，而有些人的疗效则仅有轻微改善。这种治疗效果的差异可能会导致患者不满意，并不愿意再注射。
  • 与替代疗法的竞争：皮质类固醇注射、物理治疗、口服药物、关节关节重建手术和其他替代疗法在治疗关节不适方面与透明质酸注射疗法构成竞争。如果患者和相关人员因为成本、有效性和侵入性而选择这些替代疗法，那么透明质酸注射疗法的市场潜力可能不那么高。
  • 监管障碍：透明质酸注射的监管要求和核准存在地区差异，这可能会阻碍市场进入和成长。製造商在获得产品监管批准方面遇到问题和延误，可能会延缓市场扩张。虽然透明质酸注射剂通常被认为是安全的，但人们可能担心其可能出现的副作用，包括过敏反应、感染疾病和注射部位反应。安全问题可能会削弱患者对治疗过程的信心，并使医疗保健专业人员不愿开立或实施透明质酸注射。
  • 缺乏长期数据：目前尚不清楚玻尿酸注射在一定疗程后是否长期安全有效。缺乏强有力的长期证据可能会引起患者和医疗保健专业人士对治疗效果的长期可持续性产生怀疑，从而可能阻碍市场扩张。
  • 负面社会认知：儘管有临床证据支持透明质酸注射的有效性，但某些公众群体仍可能对其抱持怀疑或负面看法。与替代疗法以及关节疾病自然发展的观点相比，这种看法尤其明显。负面认知可能会影响患者的选择和医疗专业人士的建议。

目录

第一章 引言

  • 市场概览
  • 研究范围
  • 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

  • 资料探勘
  • 验证
  • 第一手资料
  • 资料来源列表

第四章 透明质酸注射剂治疗关节疼痛的全球市场前景

  • 概述
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 波特五力模型
  • 价值链分析

第五章 全球透明质酸注射剂治疗关节疼痛市场（按类型）

  • 概述
  • 膝关节和踝关节
  • 髋关节
  • 其他的

6. 全球透明质酸注射剂治疗关节痛市场（依应用）

  • 概述
  • 医院药房
  • 零售药局
  • 其他的

7. 全球各地区玻尿酸注射治疗关节痛市场

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 世界其他地区
    • 中东和非洲
    • 南美洲

第八章全球透明质酸注射治疗关节痛市场的竞争格局

  • 概述
  • 各公司市场排名
  • 主要发展策略

第九章 公司简介

  • Allergan
  • Zimmer Biomet
  • SEIKAGAKU
  • Pfizer
  • Sanofi
  • Bioventus
  • Flexion Therapeutics
  • Anika Therapeutics
  • Ferring

第十章 附录

  • 相关调查
简介目录
Product Code: 58866

Hyaluronic Acid Injections For Joint Pain Market size was valued at USD 4.41 Billion in 2024 and is projected to reach USD 6.99 Billion by 2032, growing at a CAGR of 5.93 % from 2026 to 2032.

Global Hyaluronic Acid Injections For Joint Pain Market Drivers

The market drivers for the Hyaluronic Acid Injections For Joint Pain Market can be influenced by various factors. These may include:

  • Ageing Population: As people get older worldwide, joint-related conditions like osteoarthritis are more common. The ageing population's needs are met by hyaluronic acid injections, a less invasive therapy option for joint discomfort and improved joint function. Osteoarthritis is the most prevalent type of arthritis, impacting millions of individuals globally. Its incidence is on the rise. Because osteoarthritis is becoming more common due to factors including ageing, obesity, and sedentary lifestyles, there is a growing need for efficient treatment options, such as injections of hyaluronic acid, to reduce joint discomfort and increase mobility.
  • Preference for Non-Surgical Treatments: Before pursuing invasive procedures like joint replacement surgery, many patients would rather address their joint discomfort non-surgically. Injections of hyaluronic acid offer a non-invasive way to treat joint pain, relieving discomfort and enhancing joint performance without the dangers and extended recuperation period of surgery.
  • Technological Developments: Better hyaluronic acid injectable formulations and delivery methods have been made possible by developments in medical technology. These developments increase the treatment's effectiveness, safety, and patient comfort, which encourages patients and healthcare professionals to accept it.
  • Emphasis on Pain Management and Enhancing Quality of Life: Patients with chronic illnesses like osteoarthritis are experiencing a greater emphasis on pain management and enhancing their quality of life. With the help of hyaluronic acid injections, patients can manage their pain in a targeted manner, continue with their everyday activities, and live better.
  • Growing Healthcare Infrastructure: Access to medical therapies, such as joint pain injections using hyaluronic acid, is made easier by the growth of healthcare infrastructure, especially in emerging nations. The market for associated therapies and treatments is growing as a result of this expansion, which makes joint problems easier to diagnose and treat.
  • Growing Healthcare Spending: The market for hyaluronic acid injections for joint pain is expanding as a result of growing healthcare spending by both individuals and governments. The market for hyaluronic acid injections and related therapies is driven by patients' willingness to spend money on therapies that enhance their overall quality of life and provide efficient pain relief.
  • Clinical Evidence and Patient Satisfaction: Positive patient experiences and outcomes, in addition to mounting clinical evidence demonstrating the safety and effectiveness of hyaluronic acid injections for joint pain, drive market expansion. Treatments that have been thoroughly researched and demonstrated to have real benefits are more likely to be adopted by patients and healthcare professionals.

Global Hyaluronic Acid Injections For Joint Pain Market Restraints

Several factors can act as restraints or challenges for the Hyaluronic Acid Injections For Joint Pain Market. These may include:

  • Exorbitant Treatment Costs: Hyaluronic acid injections can be somewhat expensive, particularly for people who need repeated injections over time. Access to therapy may be hampered by this high cost, especially for those without sufficient insurance or financial means.
  • Restricted Insurance Coverage: Hyaluronic acid injection insurance coverage may be scarce or erratic in certain areas. Patients may have to pay for this out of cash, which would limit their access to the treatment-especially if they don't have full health insurance or have a poor income.
  • Efficacy Variability: The results of hyaluronic acid injections can differ from patient to patient. While some may experience considerable pain alleviation and improved joint function, others may only see minor improvements. Patients may become dissatisfied and reluctant to have repeat injections as a result of this variation in therapy response.
  • Competition from Alternative Therapies: Corticosteroid injections, physical therapy, oral drugs, joint replacement surgery, and other alternative treatments are competitors for hyaluronic acid injections as treatments for joint discomfort. Hyaluronic acid injections may not have as much market potential as they could if patients and healthcare professionals choose these alternative therapies due to considerations including cost, efficacy, and invasiveness.
  • Regulatory Obstacles: Market entry and growth may be hampered by regional variations in the regulatory requirements and approvals for hyaluronic acid injections. The expansion of the market may be slowed down by manufacturers running into problems or delays getting regulatory permission for their products. Hyaluronic acid injections are thought to be safe overall, however there may be worries about possible adverse effects such allergic responses, infections, or reactions at the injection site. Concerns about safety can undermine patients' trust in the course of treatment and make medical professionals reluctant to prescribe or carry out hyaluronic acid injections.
  • Absence of Long-Term Data: It is unclear if hyaluronic Acid Injections are safe and effective in the long run after a certain amount of treatment. The absence of strong long-term evidence may impede market expansion by raising doubts about the long-term sustainability of treatment benefits among patients and healthcare professionals.
  • Negative Public Perception: Hyaluronic acid injections may encounter scepticism or negative perceptions from certain public segments despite clinical evidence supporting their efficacy. This is especially true when comparing their worth to alternative treatments or the belief that joint conditions naturally progress. Adverse impressions have the potential to impact both patient choices and medical professional advice.

Global Hyaluronic Acid Injections For Joint Pain Market Segmentation Analysis

The Global Hyaluronic Acid Injections For Joint Pain Market is Segmented on the basis of Type, Application, And Geography.

Hyaluronic Acid Injections For Joint Pain Market, By Type

  • Knee and Ankle
  • Hip Joint
  • Others

Based on Type, the market is segmented into Knee and Ankle, Hip Joint, and Others. Knee and Ankle type is leading with the highest share in the market and is expected to grow at a decent pace during the forecast period. Obesity is linked to a variety of joint problems, particularly those affecting the knee, such as knee discomfort and osteoarthritis. Worldwide obesity has tripled since 1975, according to a fact sheet provided by the World Health Organization (WHO). In 2016, 1.9 billion people were overweight, with over 650 million adults falling into this category.

Hyaluronic Acid Injections For Joint Pain Market, By Application

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Based on Application, the market is bifurcated into, Hospital Pharmacies, Retail Pharmacies, and Others. Hospital pharmacies are leading the segment and it is expected to grow at a decent pace during the forecast period. In 2018, the hospital pharmaceutical category had the largest market share, followed by the retail sector. Its market share is predicted to continue to grow during the forecast period, owing to an increasing desire for joint pain treatment hospitals that require specialized employees for parenteral administration.

Hyaluronic Acid Injections For Joint Pain Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on Geography, the Global Hyaluronic Acid Injections For Joint Pain Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Due to a huge patient pool, a growth in the senior population, rising obesity, and high adoption of innovative treatments for joint pain alleviation in the region, North America dominates the global joint pain injections market. During the forecast period, the region is expected to maintain its dominance. Furthermore, rising healthcare expenditures and increased investments are expected to drive the Hyaluronic Acid Injections For Joint Pain Market in the coming years.

Key Players

  • The major players in the Hyaluronic Acid Injections For Joint Pain Market are
  • Allergan
  • Zimmer Biomet
  • SEIKAGAKU
  • Pfizer
  • Sanofi
  • Bioventus
  • Flexion Therapeutics
  • Anika Therapeutics
  • Ferring.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL HYALURONIC ACID INJECTIONS FOR JOINT PAIN MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL HYALURONIC ACID INJECTIONS FOR JOINT PAIN MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Knee and Ankle
  • 5.3 Hip Joint
  • 5.4 Others

6 GLOBAL HYALURONIC ACID INJECTIONS FOR JOINT PAIN MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Hospital Pharmacies
  • 6.3 Retail Pharmacies
  • 6.4 Others

7 GLOBAL HYALURONIC ACID INJECTIONS FOR JOINT PAIN MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Middle East and Africa
    • 7.5.2 South America

8 GLOBAL HYALURONIC ACID INJECTIONS FOR JOINT PAIN MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Allergan
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Zimmer Biomet
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 SEIKAGAKU
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Pfizer
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Sanofi
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Bioventus
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 Flexion Therapeutics
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 Anika Therapeutics
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Ferring
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments

10 APPENDIX

  • 10.1 Related Research